Related Experiment Videos
Acute lymphoblastic leukemia
Ching-Hon Pui1, Mary V Relling, James R Downing
1Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. ching-hon.pui@stjude.org
The New England Journal of Medicine
|April 9, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication.
Clinical cancer research : an official journal of the American Association for Cancer Research·2022
Same author
Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome.
Blood advances·2022
Same author
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Blood·2022
Same author
Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation.
Nature genetics·2022
Same author
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.
JAMA oncology·2022
Same author
Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular Care.
Children (Basel, Switzerland)·2021
Same journal
Ebola at 50 - Lessons for Outbreak Response and Preparedness.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
The New England journal of medicine·2026
Same journal
Hypertension Control in Low-Income Patients. Reply.
The New England journal of medicine·2026